MOAA0101 | Assessing individual viral reactivations of the latent reservoir using a novel barcoded virus | Oral Abstract | A14 |
MOAA0102 | Accumulation and persistence of deleted HIV proviruses following prolonged ART | Oral Abstract | A14 |
MOAA0103 | A subset of extreme HIV controllers is characterized by a small HIV blood reservoir and a weak T cell activation level | Oral Abstract | A18 |
MOAA0104 | HIV integration sites in CD4 T cells from virally suppressed individuals show clonal expansion but no preferential location in oncogenes | Oral Abstract | A4 |
MOAA0105 | The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues | Oral Abstract | A14 |
MOAA0106LB | Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression | Oral Abstract | A14 |
MOAA0201 | Sequential receptor-induced conformational states of native membrane-embedded HIV-1 Env | Oral Abstract | A3 |
MOAA0202 | Optimized Env trimer immunization parameters amplify onset, magnitude and consistency of autologous Tier 2 neutralizing antibody development in nonhuman primates | Oral Abstract | A32 |
MOAA0203 | Germinal centers monitored by lymph node fine needle aspirates correlate with and predict HIV Tier 2 neutralizing antibody responses after HIV trimer immunization | Oral Abstract | A30 |
MOAA0204 | Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows | Oral Abstract | A43 |
MOAA0205 | Killing of HIV-1-infected cells by neutralizing antibodies | Oral Abstract | A7 |
MOAA0206 | Allosteric regulation in human anti-HIV-1 Env ADCC-mediating antibodies upon immune complex (IC) formation enhances the binding to FcγRs for the activation of cytotoxicity against HIV-1 virus | Oral Abstract | A8 |
MOLBPEA01 | Majority of HIV virions exclusively express either functional or nonfunctional forms of Env | Poster Exhibition | A1 |
MOLBPEA02 | Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement | Poster Exhibition | A6 |
MOLBPEA03 | Higher levels of NK cell phenotypic diversity and transcriptional activation prior to HIV-1 infection are associated with increased set point viral load | Poster Exhibition | A6 |
MOLBPEA04 | Expanded clones in SIV-infected macaques on antiretroviral therapy recapitulate key features of expanded clones in HIV infection: implications for evaluation of “HIV Cure” interventions | Poster Exhibition | A14 |
MOLBPEA05 | Oxidative stress-related PML nuclear body degradation: a novel pharmacologically druggable mechanism behind the establishment of latency during acute infection | Poster Exhibition | A14 |
MOLBPEA06 | Estimating the contribution of proliferation to HIV-infected lymphocyte persistence | Poster Exhibition | A14 |
MOLBPEA07 | Increased levels of HIV-1 specific IgG antibody in the presence of HLA-DPB1*13 in three HIV-1 vaccine trials | Poster Exhibition | A20 |
MOLBPEA08 | Cervicovaginal bacteria and HIV acquisition in young South African women | Poster Exhibition | A21 |
MOLBPEA09 | Medroxyprogesterone acetate, unlike norethisterone, increases R5 HIV-1 replication in ecto- and endocervical explant tissue and PBMCs, at physiologically relevant concentrations, by a glucocorticoid receptor-dependent mechanism | Poster Exhibition | A21 |
MOLBPEA10 | HIV-1 up-regulates endogenous Galectin-3 to facilitate virological synapse formation and CD4+ T cell-to-cell transmission | Poster Exhibition | A25 |
MOLBPEA11 | Colorectal distribution of lymphocytes and cell-free HIV surrogate in autologous seminal plasma following simulated anal intercourse | Poster Exhibition | A26 |
MOLBPEA12 | Development and in silico evaluation of a novel formulation of oral long-acting antiretroviral therapy | Poster Exhibition | A26 |
MOLBPEA13 | Ledgins hamper the establishment of a reactivation competent HIV reservoir | Poster Exhibition | A26 |
MOLBPEA14 | A subset of bnAbs exhibit broad binding to primary CD4+ T cells infected with reactivated reservoir HIV in vitro | Poster Exhibition | A28 |
MOLBPEA15 | Rapid CTL recognition of HIV-1 latently infected cells depends on the levels of inducible viral reactivation and CTL activation status | Poster Exhibition | A28 |
MOLBPEA16 | CXCR5-transduced primary rhesus macaque CD8 T cells accumulate in B cell follicles in a novel ex vivo B cell follicle migration assay | Poster Exhibition | A29 |
MOLBPEA17 | Detection and activation of naive B cells expressing the germline precursors of protective antibodies | Poster Exhibition | A32 |
MOPDA0101 | A higher fraction of drug resistant proviruses express unspliced HIV RNA during ART compared to the archival wild-type proviruses that comprise the HIV-1 reservoir | Poster Discussion Abstract | A14 |
MOPDA0102 | Evidence of production of HIV-1 proteins from "defective" HIV-1 proviruses in vivo: implication for persistent immune activation and HIV-1 pathogenesis | Poster Discussion Abstract | A11 |
MOPDA0103 | HIV reservoirs in the brain and association with sex and neurocognition | Poster Discussion Abstract | A14 |
MOPDA0104 | Monocyte-derived reactive oxygen species impair CD4+ T cell restoration in HIV-1 patients under therapy | Poster Discussion Abstract | A11 |
MOPDA0105 | HIV-1-mediated induction of Hypoxia Inducible Factor-1 alpha activity in CD4+ T cells modifies immunometabolic phenotype and decreases cell survival | Poster Discussion Abstract | A11 |
MOPDA0106 | Toll-like receptor activation modulates inflammation and HIV-1 infection in the female reproductive tract (FEMINIVI study) | Poster Discussion Abstract | A9 |
MOPEA0001 | Evidence of substantial HIV-1 genetic evolution in vivo during suppressive therapy | Poster Exhibition | A1 |
MOPEA0002 | CRF19_cpx variant emergence in a cluster in naive patients of Southern Spain | Poster Exhibition | A1 |
MOPEA0003 | Impact of HLA-associated HIV adaptation on disease progression in Mesoamerica | Poster Exhibition | A1 |
MOPEA0004 | Heterogeneous age and genetic distribution of within-host HIV-1 reservoirs revealed by a novel phylogenetic dating strategy | Poster Exhibition | A1 |
MOPEA0005 | Subtype-specific constraints on HIV-1 adaptation to host cellular immunity revealed through statistical and functional analyses | Poster Exhibition | A1 |
MOPEA0006 | Pre-existing tuberculosis infection and associated immune reconstitution inflammatory syndrome affects the HIV-1 reservoir | Poster Exhibition | A1 |
MOPEA0007 | Evolution of HIV-1 groups M and O: genetic comparative analysis of 19 HIV-1/MO inter-group recombinant forms | Poster Exhibition | A1 |
MOPEA0008 | Proposal for an improved classification of the HIV-1 M subtype A sub-subtypes | Poster Exhibition | A1 |
MOPEA0009 | High frequency of non-subtype B infections and clustering in new HIV-1 diagnoses in Spain | Poster Exhibition | A1 |
MOPEA0010 | Relative resistance of HLA-B for downregulation by Nef is a fundamental property across lentiviral lineages | Poster Exhibition | A2 |
MOPEA0011 | Characterization of a novel dolutegravir monotherapy-associated S230R Mutation in HIV | Poster Exhibition | A2 |
MOPEA0012 | HIV-1 resistance to dolutegravir is modulated by epigenetic signals | Poster Exhibition | A2 |
MOPEA0013 | Impact of immune-driven sequence variation in Pol on viral replication capacity and disease progression in HIV-1 subtype C infection | Poster Exhibition | A2 |
MOPEA0014 | High-resolution mapping and phasing of HIV diversification in humanized mice | Poster Exhibition | A2 |
MOPEA0015 | Learning evolutionary pathways of HIV-1 subtype C under lopinavir treatment | Poster Exhibition | A2 |
MOPEA0016 | High prevalence of CXCR4-using virus in long lived latently infected naïve and central memory CD4+ T cells in individuals on ART | Poster Exhibition | A3 |
MOPEA0017 | HIV-1 transfer by T cell-macrophage fusion triggers multinucleated giant cell formation for virus spreading | Poster Exhibition | A3 |
MOPEA0018 | Investigation of tandemers activities against cell-associated HIV-1 and against viruses with decreased sensitivity to griffithsin | Poster Exhibition | A3 |
MOPEA0019 | Host microRNAs-221 and -222 inhibit HIV-1 entry of macrophages by targeting the CD4 viral receptor | Poster Exhibition | A3 |
MOPEA0020 | HIV-1 can enter and integrate the human male germ line, revealing potential for endogenization | Poster Exhibition | A3 |
MOPEA0021 | Regulation of CCR5 conformational states and export by homo-dimerization | Poster Exhibition | A3 |
MOPEA0022 | HIV-1 subtype C may possess extended coreceptor utilization in peripheral blood and the central nervous system of patients experiencing cryptococcal meningitis | Poster Exhibition | A3 |
MOPEA0023 | Alternative splicing of human APOBEC3G in HIV infection | Poster Exhibition | A3 |
MOPEA0024 | The role of CCR5 structural diversity in HIV infection | Poster Exhibition | A3 |
MOPEA0025 | Loss of SUN2 impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection in a cyclophilin A-independent manner | Poster Exhibition | A4 |
MOPEA0026 | Insights into the domains of IFITM3 involved in the negative imprinting of HIV-1 viral particles infectivity | Poster Exhibition | A4 |
MOPEA0027 | Apolipoprotein E is an HIV-1-inducible restriction factor of HIV-1 | Poster Exhibition | A4 |
MOPEA0028 | A structural study of UNG2 and its interaction with the HIV protein Vpr | Poster Exhibition | A4 |
MOPEA0029 | Regulation of retroviral integration by RNA polymerase II associated factors and chromatin structure | Poster Exhibition | A4 |
MOPEA0030 | Autophagy does not influence HIV replication in productively infected dendritic cells (DCs) | Poster Exhibition | A4 |
MOPEA0031 | p21 restricts HIV-1 replication in dendritic cells through the synergistic reduction of dNTP biosynthesis and the regulation of SAMHD1 antiviral activity | Poster Exhibition | A4 |
MOPEA0032 | Expression of native HIV-1 antisense protein (ASP) in chronically infected T cells (ACH-2) following stimulation with TNF-α | Poster Exhibition | A5 |
MOPEA0033 | Inhibition of HIV-1 gene transcription by KAP1: a new CTIP2 interactant | Poster Exhibition | A5 |
MOPEA0034 | Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity | Poster Exhibition | A5 |
MOPEA0035 | TILRR is a potential enhancer of inflammation and HIV-1 vaginal infection through interacting with NFκB signaling pathway | Poster Exhibition | A5 |
MOPEA0036 | HIV-1 Vpr counteracts CTIP2-mediated cellular response to viral infections | Poster Exhibition | A5 |
MOPEA0037 | BRD4 inhibitor, JQ1, but not HDAC inhibitors, stimulate accumulation of spliced HIV RNA | Poster Exhibition | A5 |
MOPEA0038 | Generation of HIV latency reporter cell lines by targeted genome engineering to explore effects of proviral integration site choice | Poster Exhibition | A5 |
MOPEA0039 | HIV-1 Gag interaction with Dicer and consequences on the miRNA processing and binding to the RNA interference complex | Poster Exhibition | A5 |
MOPEA0040 | Microglial cells that are latently infected by HIV are activated by inflammatory stimuli and induce neuronal damage | Poster Exhibition | A5 |
MOPEA0041 | A single-cell method to detect early activation of the latent HIV provirus | Poster Exhibition | A5 |
MOPEA0042 | The nuclear pore orchestrates HIV-1 nuclear import and sculpts the chromatin landscape near integration sites | Poster Exhibition | A5 |
MOPEA0043 | Host factors associated to control of HIV-reservoir in elite controller patients | Poster Exhibition | A14 |
MOPEA0044 | Peripheral T follicular helper cells make a difference in HIV reservoir size between elite controllers and patients on successful ART | Poster Exhibition | A14 |
MOPEA0045 | HIV-1 integration sites reveal heterogeneity in the latent population and explain the limited induction of latent proviruses | Poster Exhibition | A14 |
MOPEA0046 | HIV reservoir size and composition, after antiretroviral treatment initiation, is related to HIV-specific CD8+ T-cell responses developed during primary HIV infection | Poster Exhibition | A14 |
MOPEA0047 | Urethral tissue macrophages are genuine viral reservoirs in HIV-1-infected individuals under suppressive antiretroviral therapy | Poster Exhibition | A14 |
MOPEA0048 | Stimulation of the HIV T-cell reservoir leads to expression of genetically intact but functionally impaired Env glycoproteins | Poster Exhibition | A14 |
MOPEA0049 | Early initiation of antiretroviral treatment post SIV infection does not resolve lymphoid tissue activation | Poster Exhibition | A14 |
MOPEA0050 | A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro VOA in detecting latently infected cells from patients on ART with undetectable viral loads | Poster Exhibition | A14 |
MOPEA0051 | Suppressive myeloid cells of the human testicular interstitium: implication for HIV-1 persistence | Poster Exhibition | A14 |
MOPEA0052 | Analysis of microRNA differential expression patterns during HIV-1 reactivation to identify new molecules involved in HIV-1 latency | Poster Exhibition | A14 |
MOPEA0053 | Intact HIV-1 provirus is enriched in effector memory and HLA-DR+ memory CD4+ T cells | Poster Exhibition | A14 |
MOPEA0054 | Inhibition of HIV-1 replication in macrophages by the neuropeptides VIP and PACAP: analysis of the inhibitory potential and mechanisms | Poster Exhibition | A14 |
MOPEA0055 | Major contribution to HIV reservoirs of peripheral blood T follicular helper cells in HIV treated patients with low HIV reservoirs | Poster Exhibition | A14 |
MOPEA0056 | Contribution of peripheral blood and colon myeloid cells to HIV persistence during ART | Poster Exhibition | A14 |
MOPEA0057 | Ultrasensitive HIV-1 p24 detects single infected cells and differences in reservoir induction by latency-reversal agents | Poster Exhibition | A14 |
MOPEA0058 | The mammalian target of rapamycin is a druggable key regulator of HIV-1 permissiveness in gut-homing CCR6+ Th17 cells | Poster Exhibition | A14 |
MOPEA0059 | Massive full-length, next generation sequencing identifies clonally-expanded, genome-intact replication-competent HIV-1 in Th1 cells | Poster Exhibition | A14 |
MOPEA0060 | Role of peroxisome proliferator activated receptor-gamma in regulating inflammatory signalling in HIV-1 associated brain inflammation | Poster Exhibition | A14 |
MOPEA0061 | Factors associated with increased number of unique integration sites during early ART | Poster Exhibition | A14 |
MOPEA0062 | Characterization of the active viral reservoir by a novel single cell RNA FISH-flow method in samples from HIV-infected individuals | Poster Exhibition | A14 |
MOPEA0063 | The lungs as anatomical reservoirs of HIV: enrichment in HIV-infected cells and skewed T-cell distribution in the lungs of HIV-infected adults under suppressive ART | Poster Exhibition | A14 |
MOPEA0064 | Memory CD4+CD45RO+SAMHD1low cells exhibit distinct genes profile and contain the highest level of HIV-1 DNA with segregated HIV-1 populations | Poster Exhibition | A14 |
MOPEA0065 | 2LTR circle dynamics during integrase inhibitor monotherapy in the presence and absence of CD8+ cells | Poster Exhibition | A14 |
MOPEA0066 | HIV reservoirs in developing countries: implication for HIV CURE strategies | Poster Exhibition | A14 |
MOPEA0067 | In vivo massive expansion of a T-cell clone carrying a defective HIV genome: implication for the measurement of the HIV reservoir | Poster Exhibition | A14 |
MOPEA0068 | Inhibition of HIV-1 infection by bi-specific immunoadhesin-IgA in humanized mice | Poster Exhibition | A21 |
MOPEA0069 | The male organs source of AIDS virus in semen uncovered through phylogenetic analysis | Poster Exhibition | A21 |
MOPEA0070 | HIV cell-associated transmission in the colo-rectal mucosa ex vivo and its modulation by seminal plasma | Poster Exhibition | A21 |
MOPEA0071 | Vaginal bacteria modify HIV pre-exposure prophylaxis efficacy in African women | Poster Exhibition | A21 |
MOPEA0072 | Human seminal plasma from HIV-1-infected patients induces migration of mucosal dendritic cells and alters integrity of intestinal epithelium | Poster Exhibition | A21 |
MOPEA0073 | A combination of broadly neutralizing antibodies prevents in vitro SHIV162P3 cell-free transmission more efficiently than cell-to-cell transmission | Poster Exhibition | A21 |
MOPEA0074 | Intestinal dendritic cells and macrophages play a different role in the early events of HIV-1 transmission | Poster Exhibition | A21 |
MOPEA0075 | Virological synapses formed between HIV-1-infected CD4+ T-cells and mucosal epithelium promote macrophage infection followed by reservoir formation in reconstructed urethral tissues | Poster Exhibition | A21 |
MOPEA0076 | HIV and biologic sex differences in the risk of mother to child transmission in Cameroon | Poster Exhibition | A22 |
MOPEA0077 | Properties of ENV derived from transmitted HIV-1 issued from transmission clusters | Poster Exhibition | A24 |
MOPEA0078 | Gut-homing Δ42PD1+Vδ2 T cells promote innate mucosal damage via TLR4 during acute HIV-1 infection | Poster Exhibition | A25 |
MOPEA0079 | In depth sampling of high-risk populations to characterize HIV transmission epidemics among young MSM using PrEP in France and Quebec | Poster Exhibition | A25 |
MOPEA0080 | Very early treated acute HIV patients have high naïve-CD4+Tregs recovery with a decreased immune activation | Poster Exhibition | A25 |
MOPEA0081 | Low frequencies of HIV-infected cells in blood, colon and lymph node at the earliest stage of acute infection (Fiebig I) | Poster Exhibition | A25 |
MOPEA0082 | T follicular helper cells are preserved by ART and correlate with reservoir size in early HIV infection | Poster Exhibition | A25 |
MOPEA0083 | Evidence of fast normalization of inflammation biomarkers after ART started during acute, but not in early chronic HIV infection | Poster Exhibition | A25 |
MOPEA0084 | IL-7 is UP-regulated in the ileal mucosa during hyperacute siv infection in Chinese rhesus macaques, triggering local chemokine expressions and immune cell migrations | Poster Exhibition | A25 |
MOPEA0085 | Deep sequencing reveals viral evolution in Gag within protective HLA alleles B*57:02, B*58:01 and B*7 supertype individuals acutely infected with HIV-1 subtype C in Durban, South Africa | Poster Exhibition | A25 |
MOPEA0086 | NKp30 and its ligands: emerging players in HIV-2-infected patients | Poster Exhibition | A35 |
MOPEA0087 | Prevalence and risk factors associated with HIV/viral hepatitis B and C co-infections among people who inject drugs in Mozambique, 2013-2014 | Poster Exhibition | A36 |
MOPEA0088 | A New HIV/HBV co-infection model: hepatocytic expression of human sodium taurocholate cotransporting polypeptide (NTCP) enables hepatitis B virus infection of macaques | Poster Exhibition | A36 |
MOPEA0089 | Hepatitis B virus infection in HIV-1 negative and positive pregnant women in Botswana, implications for HBV vertical transmission | Poster Exhibition | A36 |
MOPEA0090 | Burden of HCV mono-infections and HCV/HIV co-infections in four provinces in Cambodia | Poster Exhibition | A36 |
MOPEA0091 | Dysregulation of IL-7/IL-7 receptor signaling pathway in memory CD8 T cells predicts cryptococcosis-associated immune reconstitution inflammatory syndrome | Poster Exhibition | A38 |
MOPEA0092 | Impact of minority variants on the virological response to a rilpivirine-based first-line regimen | Poster Exhibition | A40 |
MOPEA0093 | Primary HIV-1 drug resistance by massive parallel sequencing among treatment naïve HIV-infected blood donors | Poster Exhibition | A40 |
MOPEA0094 | A bioinformatic approach to determining HIV-1 drug resistance profiles in next-generation sequencing datasets | Poster Exhibition | A40 |
TUAA0101 | Evaluation of memory CD8+ T cell responses in individuals initiating cART during hyperacute HIV-1 infection | Oral Abstract | A8 |
TUAA0102 | Early anti-SIV CD8+ T cell antiviral activity is associated with durable elite control of SIV infection in macaques carrying or not protective MHC alleles: the ANRS SIC study | Oral Abstract | A42 |
TUAA0103 | CD8+ T cell depletion leads to a different profile of SIV viral decay under integrase inhibitor monotherapy | Oral Abstract | A8 |
TUAA0104 | Memory-like NK cells exploit innate priming and alternative signaling mechanisms to enhance function and mobilize at HIV/SIV mucosal portals of entry | Oral Abstract | A6 |
TUAA0105 | The human penis is an immunologically active tissue: a preliminary study on the development of an HIV vaccine | Oral Abstract | A9 |
TUAA0106LB | Efficacy of epithelial stem cell-based AIDS vaccine to induce mucosal immune responses offering protection against SIV challenge in macaques | Oral Abstract | A32 |
TUPDA0101 | Combined IL-21 and IFNα treatment limits residual inflammation and delays viral rebound in SIV-infected macaques | Poster Discussion Abstract | A28 |
TUPDA0102 | Interleukin (IL)-27 induces HIV-resistance in T cells and dendritic cells via different mechanisms: identification of YB-1 and ANKRD22 as novel host dependency factors | Poster Discussion Abstract | A29 |
TUPDA0103 | Increased effector cytotoxic lymphocytes in lymph nodes of hetIL-15 treated macaques suggest potential to disrupt SIV/HIV reservoirs | Poster Discussion Abstract | A33 |
TUPDA0104 | The human IL-15 superagonist ALT-803 activates NK and memory T cells, reactivates latent SIV and drives SIV-specific CD8+ T cells into B cell follicles | Poster Discussion Abstract | A29 |
TUPDA0105 | Tissue factor pathway inhibitor Ixolaris improves disease outcome in progressive SIVsab-infected pigtail macaques | Poster Discussion Abstract | A16 |
TUPDA0106 | Engineering HIV immunity with a chimeric antigen receptor in the non-human primate model | Poster Discussion Abstract | A29 |
TUPEA0095 | Negative checkpoint regulatory molecule 2B4 (CD244) contributes to iNKT cell dysfunction during HIV infection | Poster Exhibition | A6 |
TUPEA0096 | NK cell subset frequency and developmental markers are altered in HIV-1+ pregnancies | Poster Exhibition | A6 |
TUPEA0097 | Differential distribution of M1 and M2 macrophages in the decidua and chorionic villi of placentas from HIV-1-infected mothers on combination antiretroviral therapy | Poster Exhibition | A6 |
TUPEA0098 | Influence of the genetic LILRA3-deletion on HIV and Hepatitis C | Poster Exhibition | A6 |
TUPEA0099 | Sensing of HIV-1 entry triggers a type I interferon response in human primary macrophages | Poster Exhibition | A6 |
TUPEA0100 | In vivo analysis of LILRB2 on dendritic cells reveals specific up-regulation in early phase of SIV / HIV infection: implication in anti-viral immune responses | Poster Exhibition | A6 |
TUPEA0101 | Allogeneic NK-CD4 co-cultures reveal potential protective KIR/HLA mechanisms against HIV | Poster Exhibition | A6 |
TUPEA0102 | HIV-1 Vif adaptation to host immune pressure impact of cytidine deaminases and host HLA | Poster Exhibition | A6 |
TUPEA0103 | Blood precursor DCs are the most efficient transmitters of HIV-1 to T cells | Poster Exhibition | A6 |
TUPEA0104 | SUMOylation influences the sensitivity of SAMHD1 to Vpx-mediated degradation | Poster Exhibition | A6 |
TUPEA0105 | Interplay between infection and innate sensing mechanisms of the HIV vaccine vector MVA in human dendritic cells | Poster Exhibition | A6 |
TUPEA0106 | Plasmacytoid dendritic cells (pDC) produce Interferon-λ intrinsically, whereas BDCA3+ DC rely on cellular cross-talk, in response to HIV-1 and HIV-2 | Poster Exhibition | A6 |
TUPEA0107 | Comparison of genital tract immune mediators between HIV-infected and HIV-uninfected Malawian women randomized to the depot medroxyprogesterone acetate injectable or levonorgestrel implant | Poster Exhibition | A9 |
TUPEA0108 | Seminal plasma exposures strengthen vaccine responses in the female reproductive tract mucosae | Poster Exhibition | A9 |
TUPEA0109 | Mucosal neutrophil activation is associated with gastrointestinal and systemic T-cell activation | Poster Exhibition | A9 |
TUPEA0110 | T cell immune exhaustion in gut-associated lymphoid tissue during treated primary HIV infection: implications for HIV persistence | Poster Exhibition | A9 |
TUPEA0111 | Impaired genital wound-healing pathways in women experiencing chronic sexual abuse: implications for HIV acquisition | Poster Exhibition | A9 |
TUPEA0112 | Distribution and phenotype characterization of HIV-specific CD8 T cells in situ in the rectal mucosa of HIV+ elite controllers | Poster Exhibition | A9 |
TUPEA0113 | Sexually transmitted infections (STIs) increase levels of cytokine and cellular biomarkers of HIV risk | Poster Exhibition | A9 |
TUPEA0114 | Potential immune mechanism for the relationship between HIV risk and multiple concurrent HPV infections | Poster Exhibition | A9 |
TUPEA0115 | Degranulating immune cells are associated with higher viral load at cervico-vaginal surface of HIV-infected women in India | Poster Exhibition | A9 |
TUPEA0116 | Early antiretroviral therapy (ART) initiation improves gut mucosal immunity in SIV-infected Chinese rhesus macaques | Poster Exhibition | A9 |
TUPEA0117 | PD-1, KLRG1, and EomesoderminHigh as potential markers of CD8+ T-cell exhaustion in rectal mucosa during chronic HIV infection | Poster Exhibition | A9 |
TUPEA0118 | Enhancement of HIV-1 spreading and persistence by MIF/CD74 interaction in primary monocyte-derived macrophages (MDM) and CD4+ T-lymphocytes (CD4TL) in vitro | Poster Exhibition | A11 |
TUPEA0119 | Expression and role of chemokine fractalkine in HIV neuro-pathogenesis: a new approach to understand and treat HAND | Poster Exhibition | A11 |
TUPEA0120 | Fatty acid profiles altered by HIV infection persist despite suppressive antiretroviral therapy (ART) and are associated with immune activation in the ACTG 5248 study | Poster Exhibition | A11 |
TUPEA0121 | IP-10 and IL-18 are good markers of persistent inflammation in HIV-1 elite controllers | Poster Exhibition | A11 |
TUPEA0122 | Combination antiretroviral therapy has minimal effect on the HIV-associated expansion of adaptive, memory-like NK cells and NK cell activation | Poster Exhibition | A11 |
TUPEA0123 | Platelets of HIV-infected patients release a large amount of Growth-regulated Oncogence Alpha (GRO-a): a chemokine stimulating HIV replication | Poster Exhibition | A11 |
TUPEA0124 | Altered macrophage phenotype in HIV-infection may contribute to vascular inflammation | Poster Exhibition | A11 |
TUPEA0125 | High cannabis levels associated with decreased T cell activation in HIV-infected individuals | Poster Exhibition | A11 |
TUPEA0126 | Upregulation of chronic inflammatory cytokines despite early treatment and virological suppression in children: a role in HIV persistence? | Poster Exhibition | A11 |
TUPEA0127 | CD49d expression in T-lymphocytes subsets and cardiovascular risk in HIV-positive subjects | Poster Exhibition | A11 |
TUPEA0128 | Host determinants associated to immunological non-response in patients on cART | Poster Exhibition | A12 |
TUPEA0129 | Chronic immune activation as a cause of poor T‑helper cell migration in successfully ART‑treated HIV-1-infected individuals | Poster Exhibition | A12 |
TUPEA0130 | Reduced naïve CD8+ T-cell priming efficacy in HIV-infected patients | Poster Exhibition | A12 |
TUPEA0131 | Pre-senescent state of hematopoietic progenitors from HIV-1-infected treated patients with immunological failure | Poster Exhibition | A12 |
TUPEA0132 | Microbial dysbiosis does not alter immune activation or disease progression in SIV-infected Asian macaques | Poster Exhibition | A13 |
TUPEA0133 | Nadir CD4+ T-cell count strongly predicts gut disbyosis in HIV infection | Poster Exhibition | A13 |
TUPEA0134 | Gut dysbiosis during acute HIV infection | Poster Exhibition | A13 |
TUPEA0135 | High levels of polymicrobial vaginal communities and genital inflammation in HIV-infected women | Poster Exhibition | A13 |
TUPEA0136 | High abundance of Prevotella in gut microbiota of perinatally HIV-infected children despite suppressive antiretroviral therapy is indirectly associated with CD4 T cells | Poster Exhibition | A13 |
TUPEA0137 | The study of gorilla enteric virome dynamics: association with SIV infection | Poster Exhibition | A13 |
TUPEA0138 | Changes in the gut and blood microbiome after starting antiretroviral therapy in HIV-1-infected patients | Poster Exhibition | A13 |
TUPEA0139 | Effect of HIV on the rectal microbiome in the Chicago site of the Women's Interagency HIV Study (WIHS) | Poster Exhibition | A13 |
TUPEA0140 | Alterations in dendritic cells status and B cell subsets in HIV-1-infected children at different stages of disease | Poster Exhibition | A15 |
TUPEA0141 | Epigenetic dysregulation of the major histocompatibility complex region in HIV-infected children on antiretroviral therapy | Poster Exhibition | A15 |
TUPEA0142 | Biomarkers of progression after HIV acute/early infection: nothing compares to CD4+ T-cell count? | Poster Exhibition | A15 |
TUPEA0143 | Illicit drug use alters the composition and HIV inhibitory function of semen exosomes | Poster Exhibition | A15 |
TUPEA0144 | Multiple effects of nef on host by-stander cells: from cholesterol metabolism to epigenetic changes | Poster Exhibition | A16 |
TUPEA0145 | Comorbidities in people living with HIV (PLWHIV) compared to general population: an epidemiological analysis using a claims database in France | Poster Exhibition | A16 |
TUPEA0146 | Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controller patients | Poster Exhibition | A18 |
TUPEA0147 | Older age at infection is associated with long-term non-progression in women infected with non-subtype B HIV-1 | Poster Exhibition | A18 |
TUPEA0148 | Decrease of blood HIV reservoirs over years in HIV-controllers | Poster Exhibition | A18 |
TUPEA0149 | Post treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy | Poster Exhibition | A18 |
TUPEA0150 | Follicular helper t cell function sustains high-level specific memory B cell responses in sponstaneously controlled HIV infection | Poster Exhibition | A18 |
TUPEA0151 | Exome-wide association study in HIV-infected individuals identifies a functional variant related to long-term non progression in UBXN6 | Poster Exhibition | A18 |
TUPEA0152 | Compromised macrophage-mediated HIV trans infection of CD4 T cells is linked to lipid raft dissociation | Poster Exhibition | A18 |
TUPEA0153 | Functional characterization of a public TCR clonotype identified against the HIV-1 Gag A2-FK10 epitope | Poster Exhibition | A18 |
TUPEA0154 | Evaluation of combined protective effect of five variant genotypes on susceptibility to HIV infection in discordant couples | Poster Exhibition | A19 |
TUPEA0155 | Interleukin-21/microRNA-29 axis in natural resistance to HIV-1 infection | Poster Exhibition | A19 |
TUPEA0156 | Immune signatures linked with HIV-1 neutralization breadth | Poster Exhibition | A20 |
TUPEA0157 | Preservation of lymphopoietic potential and virus suppressive capacity by CD8+ T cells in HIV-2-infected controllers | Poster Exhibition | A20 |
TUPEA0158 | HLA-C expression levels and binding stability to β2m modulate HIV-1 infectivity | Poster Exhibition | A20 |
TUPEA0159 | HIV-specific CD8+ T cells from natural HIV-1 controllers have a distinct signature associated with enhanced metabolic plasticity and antiviral function. ANRS CO21 CODEX | Poster Exhibition | A20 |
TUPEA0160 | Functionality of tissue-resident SIV-specific CD8+ T cells | Poster Exhibition | A20 |
TUPEA0161 | NK cell capacity to accumulate in lymph node follicles is associated with SIV control | Poster Exhibition | A42 |
TUPEA0162 | Dolutegravir-based simplification of antiretroviral therapy (mono- and dual therapy) in humanized mice with chronic HIV infection | Poster Exhibition | A42 |
TUPEA0163 | Modeling viral kinetics predicts a rapid establishment of the cytotoxic immune response targeting distinct infected cell compartments in SIV controller macaques (ANRS SIC study) | Poster Exhibition | A42 |
TUPEA0164 | RNA-Seq reveals lymph node resident pDCs as the primary cellular producer of type I IFN in SIV infection | Poster Exhibition | A42 |
WEAA0101 | Impaired Nef's ability to counteract SERINC5 is associated with decreased plasma viremia | Oral Abstract | A4 |
WEAA0102 | HIV-1 concentrates and shelters cell-associated infectivity a “viral biofilm” | Oral Abstract | A14 |
WEAA0103 | Coordinated mTOR-mediated rewiring of nucleotide anabolism regulates HIV-1 infection of CD4 T lymphocytes | Oral Abstract | A4 |
WEAA0104 | Membrane-associated RING-CH (MARCH) 1 and 2 are other members of MARCH proteins that inhibit HIV-1 infection | Oral Abstract | A3 |
WEAA0105 | Bicaudal D2 facilitates the cytoplasmic trafficking and nuclear import of HIV-1 genomes during infection | Oral Abstract | A4 |
WEAA0106LB | Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1 | Oral Abstract | A5 |
WEAA0201 | Investigating the SHIV reservoir in a non-human primate model following allogeneic bone marrow transplantation | Oral Abstract | A28 |
WEAA0202 | Investigating clinical therapeutics to target infected cells and promote HIV clearance | Oral Abstract | A28 |
WEAA0203 | Inhibiting memory CD4+ T-cell self-renewal to reduce HIV persistence | Oral Abstract | A28 |
WEAA0204 | PBMCs from patients with chronic myeloid leukemia treated with different tyrosine kinase inhibitors show variable susceptibility to HIV-1 infection: searching for the best therapeutic approach | Oral Abstract | A28 |
WEAA0205 | Eradication without reactivation: suppression of HIV-1 transcription and reactivation from latency by a Tat inhibitor | Oral Abstract | A28 |
WEAA0206 | Myeloablative conditioning is dispensable for transplant-dependent HIV cure | Oral Abstract | A28 |
WEPDX0104 | Phylodynamic insights into HIV epidemic dynamics within Canada | Poster Discussion Abstract | A1 |
WEPDX0105 | Phylogenetics between and within hosts along the genome reveals transmission, dual infections, recombination and contamination | Poster Discussion Abstract | A1 |
WEPDX0106 | Deep analysis of HIV transmission chains: input of ultra-deep sequencing | Poster Discussion Abstract | A1 |
WEPEA0165 | Activity of mannose-binding lectins to enhance virus neutralization by antibodies to V1V2 and V3 loops of HIV-1 envelope | Poster Exhibition | A7 |
WEPEA0166 | IL-33 enhances the induction, durability, and breadth of the antibody response to a DNA/protein-based HIV Env vaccine | Poster Exhibition | A7 |
WEPEA0167 | Non-neutralizing antibodies targeting HIV's V1V2 domain exhibit strong inhibitory activities | Poster Exhibition | A7 |
WEPEA0168 | Antibody dependent cell-mediated phagocytic activity is increased in the genital tract mucosae of HIV-infected women with prior tenofovir gel exposure | Poster Exhibition | A7 |
WEPEA0169 | HIV-specific B cell frequency correlates with transmitted/founder virus neutralization in patients naturally controlling HIV-infection | Poster Exhibition | A7 |
WEPEA0170 | Early recovery of antibody-mediated neutralization and ADCC responses in HIV-positive individuals under dolutegravir-based antiretroviral therapy | Poster Exhibition | A7 |
WEPEA0171 | Post-translational processing influences antibody reactivity against the gp120 V2 domain on infected CD4+ T cell | Poster Exhibition | A7 |
WEPEA0172 | A unique N332 supersite directed bnAb from a slow progressor shares characteristics with both CD4bs and V3-glycan bnAbs | Poster Exhibition | A7 |
WEPEA0173 | Antibody dependent cellular cytotoxicity and neutralization antibody responses in HIV-1-infected elite controllers | Poster Exhibition | A7 |
WEPEA0174 | Identification and characterization of broadly neutralizing antibodies against founder viruses | Poster Exhibition | A7 |
WEPEA0175 | The impact of HIV-genetics on imprinting HIV-1 neutralization and binding responses | Poster Exhibition | A7 |
WEPEA0176 | Neutralizing antibodies efficiently inhibit HIV transmission from infected T cells to heterologous DC and T cells | Poster Exhibition | A7 |
WEPEA0177 | Suppression of SAMHD1 in dendritic cells improves antigen presentation and HIV-specific cytolytic T cell response in vitro | Poster Exhibition | A8 |
WEPEA0178 | Impact of a single escape mutation selected by HLA-A*24:02-restricted CD8+ T cells on HIV-1 control by HLA-B*35:01-restricted ones and T cell adaptation | Poster Exhibition | A8 |
WEPEA0179 | Control of HIV-1 by HLA-B*52:01-restricted or C*12:02-restricted cytotoxic T lymphocytes specific for 6 epitopes in an HIV-1-infected Japanese cohort, in which HLA-B*57 and HLA-B*27 are very rare | Poster Exhibition | A8 |
WEPEA0180 | Follicular cytotoxic T cells specifically control the infection in follicular helper T cells | Poster Exhibition | A8 |
WEPEA0181 | Low T cell immunogenicity of the yellow fever vaccine in HIV-infected patients: ANRS EP46 NOVAA | Poster Exhibition | A8 |
WEPEA0182 | Heterogeneity of circulating follicular helper T cells during hyperacute HIV-1 subtype C infection impact neutralizing antibody responses | Poster Exhibition | A8 |
WEPEA0183 | CD8+ T-cell suppressive capacity directly correlates with peak viral load in a cohort of virally suppressed HIV+ patients on combination antiretroviral therapy | Poster Exhibition | A8 |
WEPEA0184 | Early antiretroviral therapy intervention in HIV infection can rescue metabolic profiles of ex vivo CD8+ T cells | Poster Exhibition | A8 |
WEPEA0185 | Unilateral selection of viral mutations for escape from CD8+ T-cell recognition in SIV infection | Poster Exhibition | A10 |
WEPEA0186 | HLA-C is downregulated by most primary clones of HIV-1, and variation between these viruses is more pronounced for downregulation of HLA-C than HLA-A/B | Poster Exhibition | A10 |
WEPEA0187 | HIV-1 accessory proteins hijack membrane trafficking to downregulate CD28 | Poster Exhibition | A10 |
WEPEA0188 | Hide and seek with HIV-1 Nef: gaining super-resolution insights to immune evasion | Poster Exhibition | A10 |
WEPEA0189 | Deep sequencing analyses of emergence and maintenance of mutations in CTL epitopes of HIV-controllers with differential control of Viremia | Poster Exhibition | A10 |
WEPEA0190 | Pre-clinical pharmacokinetics of elsulfavirine/VM1500A long acting injectable formulations | Poster Exhibition | A26 |
WEPEA0191 | Generation of phage recombinant single chain variable fragment (scFv) library from pooled PBMCs of HIV-1-infected humans and identification of cross-neutralizing anti-CD4 binding site and N332 glycan dependent scFvs | Poster Exhibition | A26 |
WEPEA0192 | Complete protection of HIV-1 infection by a tandem BiIA in humanized mice and rhesus macaques | Poster Exhibition | A26 |
WEPEA0193 | Ranpirnase exhibits dose-dependent inhibition of rectal explant HIV infection and inflammatory changes | Poster Exhibition | A26 |
WEPEA0194 | A comparison study of tenofovir alafenamide (TAF) plus emtricitabine (FTC) in solution and as nanoparticles (NPs) for pre-exposure prophylaxis (PrEP) in humanized BLT (hu-BLT) mice | Poster Exhibition | A26 |
WEPEA0195 | Bevirimat-like compounds overcome HIV resistance and target different infection steps | Poster Exhibition | A26 |
WEPEA0196 | Synthesis and properties of novel soluble bifunctional CD4-mimetic small molecules containing pyridine moiety | Poster Exhibition | A26 |
WEPEA0197 | A novel therapeutic approach to prevent AIDS | Poster Exhibition | A26 |
WEPEA0198 | Novel selection approaches to identify broadly neutralizing DARPins targeting the HIV-1 envelope protein | Poster Exhibition | A26 |
WEPEA0199 | Triterpene-resistant HIV env variants show higher sensitivity to anti-V3 neutralizing antibodies | Poster Exhibition | A26 |
WEPEA0201 | New formulation of injectable and removable long-acting dolutegravir is effective in prevention of HIV transmission with high dose vaginal HIV challenges | Poster Exhibition | A26 |
WEPEA0202 | A novel NRTI, EFdA, effectively penetrates and suppresses HIV infection in all individual compartments of male genital tract | Poster Exhibition | A26 |
WEPEA0203 | Preclinical characterization of a potent D-peptide inhibitor of HIV entry: cholesterol-conjugated PIE12-trimer (CPT31) | Poster Exhibition | A26 |
WEPEA0204 | RNA-induced epigenetic silencing of HIV-1 involves actin regulators, Arp2 and Formin-like 1 protein | Poster Exhibition | A27 |
WEPEA0205 | Characterization of novel and potent U1 interference RNAs targeting the Gag open reading frame of HIV-1 | Poster Exhibition | A27 |
WEPEA0206 | A new highly sensitive retinoic acid-based viral outgrowth assay to detect replication-competent HIV reservoir | Poster Exhibition | A28 |
WEPEA0207 | The PPARγ antagonism inhibits HIV replication while restoring effector functions in Th17 cells | Poster Exhibition | A28 |
WEPEA0208 | HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption | Poster Exhibition | A28 |
WEPEA0209 | Sphingosine-1-phosphate receptor 1 agonists as HIV-1 latency reversing agents | Poster Exhibition | A28 |
WEPEA0210 | Monocyte co-culture can reverse pre-activation but not post-activation latency | Poster Exhibition | A28 |
WEPEA0211 | The activation of NF-kB and the subsequent transcription of latent HIV-1 in resting CD4+ T cells is the direct consequence of MVC binding to CCR5 | Poster Exhibition | A28 |
WEPEA0212 | Antiretroviral drug transporters and metabolic enzymes expressed in the testes could potentially contribute to low tissue drug concentrations and HIV-1 persistence | Poster Exhibition | A28 |
WEPEA0213 | Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV | Poster Exhibition | A28 |
WEPEA0214 | Latency reversing agents induce differential responses in distinct memory CD4+ T cell subsets in virally suppressed individuals | Poster Exhibition | A28 |
WEPEA0215 | A novel strategy to circumvent cytokine release associated with HIV latency reversal | Poster Exhibition | A28 |
WEPEA0216 | Early initiation of long-term ART may favor interventions to eradicate HIV: analysis of cell turnover and persistent HIV reservoir in distinct CD4+ T cell subpopulations in suppressed HIV disease | Poster Exhibition | A28 |
WEPEA0217 | Replication competent HIV reservoirs resist elimination by CTLs and potent combinations of latency-reversing agents | Poster Exhibition | A28 |
WEPEA0218 | 4-Deoxyphorbol derivatives as new drug candidates for “Shock and Kill” therapy with strong activity against HIV-1 | Poster Exhibition | A28 |
WEPEA0219 | Stress increases HIV transcription in HIV-infected individuals on antiretroviral therapy: implications for biomarkers of HIV persistence | Poster Exhibition | A28 |
WEPEA0220 | HIV-1 Nef blockade improves the immune recognition and clearance of primary latently HIV-1-infected CD4 T cells by autologous CD8 T cells | Poster Exhibition | A28 |
WEPEA0221 | Panobinostat distribution in rhesus macaque lymph nodes following anti-latency therapy | Poster Exhibition | A28 |
WEPEA0222 | Vorinostat renders the replication-competent latent reservoir of HIV vulnerable to clearance by CD8 T cells | Poster Exhibition | A28 |
WEPEA0223 | HIV-1 Nef is required for efficient latency reversal in a T cell line | Poster Exhibition | A28 |
WEPEA0224 | IFITM1 targets HIV-1 latently infected cells for antibody dependent cytolysis | Poster Exhibition | A28 |
WEPEA0225 | Early treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection | Poster Exhibition | A28 |
WEPEA0226 | The central nervous system as a reservoir of HIV-1 variants resistant to broadly neutralizing antibodies | Poster Exhibition | A29 |
WEPEA0227 | Knockdown of CCR5 expression in antigen-specific CD4 T cells | Poster Exhibition | A29 |
WEPEA0228 | Structures within the coreceptor binding site account for the broad neutralizing activity of single chain variable fragments (scFv) targeting CD4-induced epitopes | Poster Exhibition | A29 |
WEPEA0229 | Jak inhibitors employ novel mechanisms to block reservoir seeding and HIV persistence | Poster Exhibition | A29 |
WEPEA0230 | CTL-based vaccine-induced control is associated with induction of high follicular to extra-follicular ratios of virus-specific CD8+ T cells | Poster Exhibition | A30 |
WEPEA0231 | Deciphering the first steps of the local immune response after intradermal vaccination with recombinant MVA | Poster Exhibition | A30 |
WEPEA0232 | Innate myeloid responses are highly diverse and strongly differ after the priming and the boosting immunizations | Poster Exhibition | A30 |
WEPEA0233 | Novel pDNA prime-boost vaccine strategy combining gag and Env elicits broad cytotoxic T cell and antibody responses targeting conserved subdominant gag and Env epitopes of HIV and SIV | Poster Exhibition | A30 |
WEPEA0234 | Effective priming of CD8+ T cells with ability to suppress HIV-1 replication using STING ligand | Poster Exhibition | A31 |
WEPEA0235 | Use of encapsulated NOD2 ligands for increasing germinal centers and enhancing HIV humoral responses | Poster Exhibition | A31 |
WEPEA0236 | Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity | Poster Exhibition | A32 |
WEPEA0237 | HIV-1 conserved mosaics delivered by regimens with integration-deficient, DC-targeting lentiviral vector induce robust T cells | Poster Exhibition | A32 |
WEPEA0238 | Langerhans cells targeted with anti-Langerin monoclonal antibodies fused with HIV antigens promote the differentiation of naïve CD4+ T cells towards Tfh cells | Poster Exhibition | A32 |